Dupont Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Dupont Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,289	Closed	-$156K	–	1685
2022 Q2	$156K	Hold	14,289	–	–	0.01%	1051
2022 Q1	$162K	Sell	14,289 -1,264	-8%	-$16.6K	0.01%	1143
2021 Q4	$244K	Sell	15,553 -6,201	-29%	-$108K	0.01%	1052
2021 Q3	$373K	Sell	21,754 -26,915	-55%	-$471K	0.01%	1006
2021 Q2	$1.05M	Hold	48,669	–	–	0.02%	560
2021 Q1	$731K	Sell	48,669 -9,982	-17%	-$162K	0.02%	735
2020 Q4	$771K	Buy	+58,651	New	+$706K	0.02%	669
2020 Q1	–	Sell	-24,896	Closed	-$409K	–	1383
2019 Q4	$409K	Hold	24,896	–	–	0.01%	931
2019 Q3	$331K	Buy	+24,896	New	+$347K	0.01%	957
2019 Q2	–	Sell	-28,171	Closed	-$518K	–	1272
2019 Q1	$518K	Sell	28,171 -16,996	-38%	-$387K	0.01%	744
2018 Q4	$1.18M	Hold	45,167	–	–	0.03%	490
2018 Q3	$1.04M	Hold	45,167	–	–	0.02%	557
2018 Q2	$860K	Hold	45,167	–	–	0.02%	590
2018 Q1	$761K	Sell	45,167 -28,703	-39%	-$480K	0.02%	587
2017 Q4	$1.12M	Hold	73,870	–	–	0.03%	494
2017 Q3	$1.32M	Buy	+73,870	New	+$1.24M	0.03%	462

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Dupont Capital Management's VNDA Position: Q3 2022 in Review

Dupont Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q3 2022, closing a stake of 14,289 shares — an estimated $156K sold.

Dupont Capital Management first reported a position in VNDA in Q3 2017 and held it in 16 quarters. The position peaked at $1.32M in Q3 2017. 178 funds tracked by Wall St. Rank hold VNDA as of Q3 2022.

Dupont Capital Management reported no remaining Vanda Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Dupont Capital Management sold 14,289 Vanda Pharmaceuticals shares in Q3 2022, an estimated $156K.
Dupont Capital Management first reported a position in Vanda Pharmaceuticals in Q3 2017 and held it in 16 quarters.
Dupont Capital Management's Vanda Pharmaceuticals position peaked at $1.32M in Q3 2017.
178 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2022.

Based on Dupont Capital Management's 13F filing for Q3 2022, filed 31 Oct 2022.